Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasmodium Falciparum Malaria”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03896724
What this trial is testing

Safety, Immunogenicity and Efficacy of R21 Matrix-M in 5-17 Month Old Children in Nanoro, Burkina Faso

Who this might be right for
Malaria,Falciparum
University of Oxford 450
Not applicableStudy completedNCT00157833
What this trial is testing

Trial of Coartemether and Artekin for the Treatment of Uncomplicated Malaria in Papua, Indonesia.

Who this might be right for
Falciparum MalariaVivax Malaria
Menzies School of Health Research 750
Large-scale testing (Phase 3)Study completedNCT00701961
What this trial is testing

Pharmacokinetic of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnancy

Who this might be right for
Plasmodium Falciparum Malaria
Institute of Tropical Medicine, Belgium 48
Early research (Phase 1)Study completedNCT00317473
What this trial is testing

Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children

Who this might be right for
Plasmodium Falciparum Malaria
U.S. Army Medical Research and Development Command 135
Testing effectiveness (Phase 2)Looking for participantsNCT07559370
What this trial is testing

Safety and Efficacy of Imatinib in Combination With Artemether-Lumefantrine for Uncomplicated Malaria

Who this might be right for
Malaria (Plasmodium Falciparum)
Victoria Biomedical Research Institute 1,116
Not applicableStudy completedNCT01280162
What this trial is testing

Malaria Active Epidemiology and Treatment Study

Who this might be right for
Malaria
Armed Forces Research Institute of Medical Sciences, Thailand 222
Early research (Phase 1)Study completedNCT01867463
What this trial is testing

Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 230
Testing effectiveness (Phase 2)Study completedNCT00147368
What this trial is testing

Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria

Who this might be right for
Malaria, Falciparum
Menzies School of Health Research 50
Early research (Phase 1)Study completedNCT02783820
What this trial is testing

Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A

Who this might be right for
Malaria
Medicines for Malaria Venture 24
Not applicableStudy completedNCT00544024
What this trial is testing

Mefloquine Bioequivalence Among 3 Commercially Available Tablets.

Who this might be right for
Malaria
Centers for Disease Control and Prevention 39
Testing effectiveness (Phase 2)Study completedNCT00519467
What this trial is testing

Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria

Who this might be right for
Malaria
GlaxoSmithKline 120
Testing effectiveness (Phase 2)Study completedNCT07060508
What this trial is testing

L9LS in Women of Childbearing Potential in Mali

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 279
Early research (Phase 1)Ended earlyNCT04130282
What this trial is testing

VAC077: Safety and Immunogenicity of the Pfs25-IMX313/Matrix-M Vaccine

Who this might be right for
Malaria,Falciparum
University of Oxford 1
Testing effectiveness (Phase 2)Study completedNCT02831023
What this trial is testing

Phase 2 Efficacy Study of Primaquine and Methylene Blue

Who this might be right for
Malaria
University of California, San Francisco 80
Not applicableStudy completedNCT04037332
What this trial is testing

Monitoring of Molecular Markers of Artemisinin Resistance Through Repeated Cross-sectional Assessments in DR Congo, Nigeria and Uganda

Who this might be right for
Severe Malaria
Swiss Tropical & Public Health Institute 916
Post-approval studies (Phase 4)Not Yet RecruitingNCT07713602
What this trial is testing

Study to Assess Safety and Clinical Responses With Coartem® Baby Dispersible Tablets in Paediatric Patients Weighing 2 to <5 kg With Uncomplicated Malaria

Who this might be right for
Malaria
Novartis Pharmaceuticals 20
Not applicableStudy completedNCT01736319
What this trial is testing

Artemisinin-resistant Malaria in Cambodia

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 561
Testing effectiveness (Phase 2)Study completedNCT01397227
What this trial is testing

Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model

Who this might be right for
Malaria
Crucell Holland BV 36
Not applicableStudy completedNCT00203801
What this trial is testing

Combination Antimalarials in Uncomplicated Malaria

Who this might be right for
Malaria
University of Cape Town 700
Post-approval studies (Phase 4)Study completedNCT00167739
What this trial is testing

Treatment of Malaria With Quinine Plus Sulfadoxine-Pyrimethamine

Who this might be right for
Malaria
Albert Schweitzer Hospital 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation